Qiming U.S. Ventures Management

Latest statistics and disclosures from Qiming U.S. Ventures Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are JSPR, KRRO, TRML, HLVX, VTYX, and represent 99.06% of Qiming U.S. Ventures Management's stock portfolio.
  • Qiming U.S. Ventures Management has $53M in assets under management (AUM), dropping by -41.33%.
  • Central Index Key (CIK): 0001909617

Tip: Access up to 7 years of quarterly data

Positions held by Qiming U.S. Ventures Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Qiming U.S. Ventures Management

Qiming U.S. Ventures Management holds 6 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Jasper Therapeutics Com New (JSPR) 40.1 $21M 929k 22.70
 View chart
Korro Bio (KRRO) 23.7 $13M 368k 33.87
 View chart
Tourmaline Bio (TRML) 18.1 $9.5M 742k 12.86
 View chart
Hillevax (HLVX) 15.4 $8.1M 559k 14.46
 View chart
Ventyx Biosciences (VTYX) 1.8 $952k 412k 2.31
 View chart
Kezar Life Sciences (KZR) 0.9 $497k 829k 0.60
 View chart

Past Filings by Qiming U.S. Ventures Management

SEC 13F filings are viewable for Qiming U.S. Ventures Management going back to 2021